Oncogenic activity and cellular functionality of melanoma associated antigen A3-Reference-Cited by-同舟云学术

Oncogenic activity and cellular functionality of melanoma associated antigen A3

Published:2021-10 Issue: Volume:192 Page:114700
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Schäfer Paula^ORCID,Paraschiakos Themistoklis,Windhorst Sabine

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference69 articles.

1. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases;Coley;1893, Clin. Orthop. Relat. Res.,1991

2. Cancer immunotherapy: harnessing the immune system to battle cancer;Yang;J. Clin. Invest.,2015

3. Revisiting the role of CD4(+) T cells in cancer immunotherapy-new insights into old paradigms;Tay;Cancer Gene Ther.,2021

4. Production of stable cytolytic T-cell clones directed against autologous human melanoma;Hérin;Int. J. Cancer,1987

5. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes;Gaugler;J. Exp. Med.,1994

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer;Cancers;2024-01-05

2. Novel affibody molecules as potential agents in molecular imaging for MAGE-A3-positive tumor diagnosis;Environmental Research;2023-11

3. Recent Advances in Molecular Mechanisms of Cancer Immunotherapy;Cancers;2023-05-11

4. Ex Vivo Model of Neuroblastoma Plasticity;Cancers;2023-02-17

5. Adjuvant DNA vaccine pNMM promotes enhanced specific immunity and anti-tumor effects;Human Vaccines & Immunotherapeutics;2023-01-02